Rare diseases
Investigational molecules
Locations
Calle Del Doctor Esquerdo 46, 28009 Madrid, Spain
Hospital General Universitario Gregorio Maranon in Madrid, Spain specialises in clinical trials of conditions such as Non-small cell lung cancer, Breast cancer, Hepatocellular carcinoma, Plasma cell myeloma, and other specialisations. This site conducts important research.
Research at Hospital General Universitario Gregorio Maranon focuses on blood‑related cancers, aiming to improve survival and reduce treatment‑related toxicity.
Additional info: trials test novel targeted agents, cellular therapies and maintenance strategies to achieve deeper remissions.
Investigations target a broad range of solid tumors, evaluating new targeted drugs and combination regimens to extend progression‑free survival.
Additional info: many studies incorporate biomarker‑driven enrollment such as KRAS, EGFR, HER2, and PD‑L1 status.
Trials address immune‑mediated conditions, testing innovative biologics and small molecules to control disease activity.
Additional info: objectives include improving quality of life and reducing flare frequency.
Research explores therapies for heart disease and metabolic disorders, seeking to lower event rates and improve organ function.
Additional info: studies often evaluate anti‑inflammatory or metabolic pathways such as IL‑6 inhibition.
Clinical work includes chronic liver conditions and digestive‑tract cancers, aiming to halt disease progression and alleviate symptoms.
Additional info: endpoints frequently involve liver fibrosis regression and patient‑reported itch scores.
Studies address severe infections and post‑transplant complications, testing antivirals, antibiotics, and immune‑modulating protocols.
Additional info: safety and infection‑control outcomes are primary measures.
Clinical trials currently enrolling participants at this site.
SpainA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
SpainLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
SpainOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
SpainA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
SpainStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
SpainStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
SpainPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
SpainA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
SpainA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
SpainStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
SpainA study of navenibart for long-term safety in patients with hereditary angioedema
SpainMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
